Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Paediatric HIV care in sub-Saharan Africa: clinical presentation and 2-year outcomes stratified by age group.

Ben-Farhat J, Gale M, Szumilin E, Balkan S, Poulet E, Pujades-Rodríguez M.

Trop Med Int Health. 2013 Sep;18(9):1065-1074. doi: 10.1111/tmi.12142. Epub 2013 Jun 20.

2.

Mortality and clinical outcomes in children treated with antiretroviral therapy in four African vertical programmes during the first decade of paediatric HIV care, 2001-2010.

Ben-Farhat J, Schramm B, Nicolay N, Wanjala S, Szumilin E, Balkan S, Pujades-Rodríguez M.

Trop Med Int Health. 2017 Mar;22(3):340-350. doi: 10.1111/tmi.12830. Epub 2017 Jan 26.

PMID:
27992677
3.

How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa.

Slaymaker E, Todd J, Marston M, Calvert C, Michael D, Nakiyingi-Miiro J, Crampin A, Lutalo T, Herbst K, Zaba B.

Glob Health Action. 2014 Apr 22;7:22789. doi: 10.3402/gha.v7.22789. eCollection 2014.

4.

Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.

Alvarez-Uria G, Naik PK, Pakam R, Midde M.

Glob Health Action. 2013 Sep 12;6:21682. doi: 10.3402/gha.v6i0.21682.

5.
6.

Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.

Koole O, Tsui S, Wabwire-Mangen F, Kwesigabo G, Menten J, Mulenga M, Auld A, Agolory S, Mukadi YD, Colebunders R, Bangsberg DR, van Praag E, Torpey K, Williams S, Kaplan J, Zee A, Denison J.

Trop Med Int Health. 2014 Dec;19(12):1397-410. doi: 10.1111/tmi.12386. Epub 2014 Sep 17.

7.

Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.

Bastard M, Poulet E, Nicolay N, Szumilin E, Balkan S, Pujades-Rodriguez M.

Pediatr Infect Dis J. 2016 Sep;35(9):981-6. doi: 10.1097/INF.0000000000001213.

PMID:
27187757
8.

Characteristics of HIV-infected children seen in Western Kenya.

Nyandiko WM, Mwangi A, Ayaya SO, Nabakwe EC, Tenge CN, Gisore PM, Vreeman RC.

East Afr Med J. 2009 Aug;86(8):364-73.

PMID:
20575310
9.

The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.

Braitstein P, Nyandiko W, Vreeman R, Wools-Kaloustian K, Sang E, Musick B, Sidle J, Yiannoutsos C, Ayaya S, Carter EJ.

Pediatr Infect Dis J. 2009 Jul;28(7):626-32. doi: 10.1097/INF.0b013e31819665c5.

PMID:
19451858
10.

Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.

Sengayi M, Dwane N, Marinda E, Sipambo N, Fairlie L, Moultrie H.

Glob Health Action. 2013 Jan 24;6:19248. doi: 10.3402/gha.v6i0.19248.

11.

Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi.

Brophy JC, Hawkes MT, Mwinjiwa E, Mateyu G, Sodhi SK, Chan AK.

PLoS One. 2016 Nov 3;11(11):e0165772. doi: 10.1371/journal.pone.0165772. eCollection 2016.

12.

Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.

Stockdale AJ, Nkuranga J, Török ME, Faragher B, Lalloo DG.

Trop Med Int Health. 2013 Jul;18(7):907-14. doi: 10.1111/tmi.12110. Epub 2013 Apr 17.

13.

Mortality and loss to follow-up in the first year of ART: Malawi national ART programme.

Weigel R, Estill J, Egger M, Harries AD, Makombe S, Tweya H, Jahn A, Keiser O.

AIDS. 2012 Jan 28;26(3):365-73. doi: 10.1097/QAD.0b013e32834ed814.

14.

Mortality of HIV-infected and uninfected children in a longitudinal cohort in rural south-west Uganda during 8 years of follow-up.

Munyagwa M, Baisley K, Levin J, Brian M, Grosskurth H, Maher D.

Trop Med Int Health. 2012 Jul;17(7):836-43. doi: 10.1111/j.1365-3156.2012.03000.x. Epub 2012 May 16.

15.

Treatment initiation, program attrition and patient treatment outcomes associated with scale-up and decentralization of HIV care in rural Malawi.

McGuire M, Pinoges L, Kanapathipillai R, Munyenyembe T, Huckabee M, Makombe S, Szumilin E, Heinzelmann A, Pujades-Rodríguez M.

PLoS One. 2012;7(10):e38044. doi: 10.1371/journal.pone.0038044. Epub 2012 Oct 15.

16.

Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya.

Braitstein P, Katshcke A, Shen C, Sang E, Nyandiko W, Ochieng VO, Vreeman R, Yiannoutsos CT, Wools-Kaloustian K, Ayaya S.

Trop Med Int Health. 2010 Jul;15(7):833-41. doi: 10.1111/j.1365-3156.2010.02539.x. Epub 2010 May 14.

17.

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.

Crook AM, Turkova A, Musiime V, Bwakura-Dangarembizi M, Bakeera-Kitaka S, Nahirya-Ntege P, Thomason M, Mugyenyi P, Musoke P, Kekitiinwa A, Munderi P, Nathoo K, Prendergast AJ, Walker AS, Gibb DM; ARROW Trial Team.

BMC Med. 2016 Mar 23;14:50. doi: 10.1186/s12916-016-0593-7.

18.

Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa.

KIDS-ART-LINC Collaboration.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):523-31. doi: 10.1097/QAI.0b013e31818aadce.

PMID:
18989227
19.

Growth in HIV-infected children on long-term antiretroviral therapy.

Feucht UD, Van Bruwaene L, Becker PJ, Kruger M.

Trop Med Int Health. 2016 May;21(5):619-29. doi: 10.1111/tmi.12685. Epub 2016 Mar 21.

20.

Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.

Spillane H, Nicholas S, Tang Z, Szumilin E, Balkan S, Pujades-Rodriguez M.

Trop Med Int Health. 2012 Oct;17(10):1255-63. doi: 10.1111/j.1365-3156.2012.03056.x. Epub 2012 Aug 5.

Supplemental Content

Support Center